RNA Virus Infections clinical trials at University of California Health

2 in progress, 0 open to eligible people

Showing trials for

  • Enhancing Innate Anti-Viral Resistance Through A Community-Based Intervention - Generation Xchange

    Sorry, accepting new patients by invitation only

    This randomized controlled trial will test whether a recently developed community-based intergenerational mentoring program known as Generation Xchange (GenX) can enhance antiviral resistance in older African-American women and men in a low-SES urban community. Additional studies will identify the biological processes that promote resistance to respiratory virus infections and viral disease in older African-American women and men.

    at UCLA

  • Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19

    Sorry, in progress, not accepting new patients

    This study is a Phase 1 / 2 trial to determine the safety and efficacy of CYNK-001, an immunotherapy containing Natural Killer (NK) cells derived from human placental CD34+ cells and culture-expanded, in patients with moderate COVID-19 disease.

    at UC Davis UC Irvine

Our lead scientists for RNA Virus Infections research studies include .

Last updated: